SCHEMBL4607984

SCHEMBL4607984

Cc1[nH]c2ccccc2c1-c1ccc(O)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 4/20 0.69
ESR2 Q92731 4/20 0.69
IMPDH2 P12268 1/20 0.65
PTGS2 P35354 3/20 0.52
AHR P35869 1/20 0.50
ALDH1A1 P00352 4/20 0.49
KDM4E B2RXH2 3/20 0.49
MAPT P10636 3/20 0.49
LMNA P02545 2/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
HPGD P15428 2/20 0.49
NPSR1 Q6W5P4 1/20 0.49
HSD17B10 Q99714 1/20 0.49
GSK3B P49841 1/20 0.48
ADK P55263 1/20 0.48
CYP1A2 P05177 2/20 0.46
CYP2C9 P11712 2/20 0.46
CCR6 P51684 1/20 0.46
HKDC1 Q2TB90 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16169793 0.85 IMPDH2 (0.69) ESR1ESR2IMPDH2PTGS2AHR
SCHEMBL17383846 0.85 IMPDH2 (0.73) ESR1ESR2IMPDH2PTGS2AHR
SCHEMBL6986423 0.82 IMPDH2 (0.65) ESR1ESR2IMPDH2PTGS2AHR
SCHEMBL27701196 0.82 IMPDH2 (0.65) ESR1ESR2IMPDH2PTGS2AHR
SCHEMBL8722197 0.82 IMPDH2 (0.65) ESR1ESR2IMPDH2PTGS2AHR
SCHEMBL7037980 0.81 ESR1 (1.00) ESR1ESR2PTGS2
SCHEMBL28105642 0.81 ESR1 (0.73) ESR1ESR2PTGS2AHRALDH1A1
SCHEMBL14045573 0.80 ESR1 (0.56) ESR1ESR2IMPDH2PTGS2ALDH1A1
SCHEMBL5195800 0.79 IMPDH2 (0.49) ESR1ESR2IMPDH2ALDH1A1KDM4E
SCHEMBL11459527 0.79 CHEK1 (0.54) ESR1ESR2IMPDH2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1945206-A1 INDOLE DERIVATIVES AS HISTAMINE 3 RECEPTOR INHIBITORS FOR THE TREATMENT OF COGNITIVE AND SLEEP DISORDERS, OBESITY AND OTHER CNS DISORDERS Athersys, Inc. (US) 2008-07-23 EP disclosed
WO-2007047775-A1 INDOLE DERIVATIVES AS HISTAMINE 3 RECEPTOR INHIBITORS FOR THE TREATMENT OF COGNITIVE AND SLEEP DISORDERS, OBESITY AND OTHER CNS DISORDERS ATHERSYS, INC. (US) 2007-04-26 WO disclosed